Pharmaceutical product patents are in direct competition with the once-thriving generic drug industry. Iain Gillespie, a professor at the University of Leicester, explains how the European Union halted the success of generic drugs and how the Canadian approach differs.
Series: Innovation in Context
Leading thinkers from around the globe look at how societal conditions foster successful innovations
